Skip to content

Study to investigate the correlation between Peak Nasal Inspiratory Flow with sleep-related symptoms in Allergic Rhinitis

Study to investigate the correlation between Peak Nasal Inspiratory Flow with sleep-related symptoms in Allergic Rhinitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-16010045
Enrollment
Unknown
Registered
2016-11-21
Start date
2016-11-24
Completion date
Unknown
Last updated
2018-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Case series:Peak Nasal Inspiratory Flow meter

Sponsors

The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Both genders of 18 years and over; 2. Abbreviated Mental Test>=6; 3. Ability to understand the nature, scope and possible consequences of the study; 4. Capability and willingness to comply with the requirements of the protocol.

Exclusion criteria

Exclusion criteria: 1. With co-existing nasal conditions other than AR, which may affect nasal pathology (nasal polyposis, sinusitis, severe deviations of nasal septum, tumours of the nasal cavity, acute/chronic rhinosinusitis, or any underlying pathology that might affect nasal breathing or nocturnal sleep); 2. With prior nasal surgery eg. surgery performed in nasal cavity, sinuses; 3. History of known sleep disorder, central and obstructive sleep apnoea, narcolepsy, insomnia, patients requiring regular sleep medication and those hypersensitive to applied topical nasal steroids; 4. Respiratory tract infection within the past 30 days; 5. Clinically major cardiovascular, respiratory, hepatic, neurological, endocrine, immunological, or other major systemic diseases; 6. History of drug or alcohol abuse; 7. On concurrent immunosuppressive therapy or systemic steroid treatment; 8. On other medications that could affect nasal/ocular symptoms, sleep/daytime performance eg. decongestants, anti-inflammatory drugs, oral/long acting inhaled beta-agonist, sleeping pills; 9. On self-prescribed rhinitis or sleep medication; 10. Unable to perform PNIF by himself/herself.

Design outcomes

Primary

MeasureTime frame
Nasal flow and patency;

Secondary

MeasureTime frame
7-day sleep diary including information on sleep onset latency, total sleep time, frequency of nightly awakenings, sleep quality, mood, alertness, daytime fatigue etc.;Rhinitis condition scoring;Sleep quality;Objective inferior turbinate gradin;

Countries

China

Contacts

Public ContactMichael Tong

Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong

mtong@ent.cuhk.edu.hk+852 26322628

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026